RARECast

A podcast by RARECast - Thursdays

Thursdays

Categories:

516 Episodes

  1. Raising Awareness in a Town with a History of a Rare Disease

    Published: 3/8/2017
  2. Helping Rare Disease Patients Navigate the World of Information

    Published: 3/1/2017
  3. Overcoming the Challenges of Rare Disease Drug Development

    Published: 2/22/2017
  4. Moving Rare Disease Therapies from Hope to Reality

    Published: 2/15/2017
  5. Children’s National Launches First-of-its-Kind Rare Disease Center

    Published: 2/8/2017
  6. A Common Link in a Group of Rare Diseases Creates an Opportunity for Repurposing

    Published: 2/1/2017
  7. Sobi Works to Expand Rare Disease Indications for Its Drugs

    Published: 1/25/2017
  8. Why Rare Disease Patients Should Work Together to Address Common Concerns

    Published: 1/18/2017
  9. Solving Medical Mysteries with the Wisdom of Crowds

    Published: 1/11/2017
  10. Embracing Collaborations to Drive Development of Rare Disease Therapies

    Published: 1/4/2017
  11. Determining If a Child's Neurologic or Psychiatric Symptoms are Caused by an Infection

    Published: 12/28/2016
  12. Helping Patients with the Same Undiagnosed Genetic Condition Find Each Other

    Published: 12/21/2016
  13. An Entrepreneur Uses a Silicon Valley Approach to Tackle Rare Disease

    Published: 12/14/2016
  14. Looking for Love with a Rare Disease

    Published: 12/7/2016
  15. Why Genomics May Be in Google's DNA

    Published: 11/29/2016
  16. The Power of Small Grants to Make Big Impacts

    Published: 11/23/2016
  17. Building an International Registry for Rare Diseases

    Published: 11/16/2016
  18. Discovering the Creative Use of Outrage

    Published: 11/9/2016
  19. Diagnosing Rare Diseases with Facial Analysis

    Published: 11/2/2016
  20. Charles River Sees Opportunity in Fostering Rare Disease Collaborations

    Published: 10/27/2016

21 / 26

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.